Health CatalystHCAT -1.71%49 Days Payable is 27.22 as of Mar. 2026, which is 107% above its 10-year median of 13.16. GuruFocus rates HCAT with a GF Score™ of 49/100 and a GF Value™ of $5.06 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 608 Healthcare Providers & Services companies, Health Catalyst ranks worse than 83.22% on this metric.
The historical rank and industry rank for Health Catalyst's Days Payable or its related term are showing as below:
HCAT'
s Days Payable Range Over the Past 10 Years
Min: 6.97 Med: 13.16 Max: 23.8
Current: 21.14
During the past 9 years, Health Catalyst's highest Days Payable was 23.80. The lowest was 6.97. And the median was 13.16.
HCAT's Days Payable is ranked worse than 83.22% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 58.08
vs HCAT: 21.14
Health Catalyst's Days Payable
increased
from Mar. 2025 (21.53) to Mar. 2026 (27.22).
It may suggest that Health Catalystdelayed paying its suppliers.
Health Catalyst Days Payable Related Terms
Health Catalyst Days Payable Historical Data
* Premium members only.
The historical data trend for Health Catalyst's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Health Catalyst's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health Catalyst Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's Days Payable distribution charts can be found below:
* The bar in red indicates where Health Catalyst's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Health Catalyst's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health Catalyst (HCAT) has a Days Payable of 27.22 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Health Catalyst and its competitors. This is 107% above median its historical median of 13.16. Over the past decade, Health Catalyst's Days Payable has ranged from 6.97 to 23.80. According to the industry distribution chart, Health Catalyst ranks #506 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 83.2%.
Is Health Catalyst's Days Payable too high?
Health Catalyst's current Days Payable of 27.22 is 107% above median its 10-year median of 13.16. Over the past 10 years, this metric has ranged from a low of 6.97 to a high of 23.80. The Healthcare Providers & Services industry median Days Payable is 58.08. Health Catalyst's value of 27.22 is 53.1% below this industry median. Based on the distribution chart, Health Catalyst ranks #506 out of 608 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Health Catalyst has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Health Catalyst's Days Payable compare to CCLD and DH?
According to the Healthcare Providers & Services industry distribution chart, Health Catalyst ranks #506 out of 608 companies for Days Payable. This places Health Catalyst in the lower half of its industry. The industry median Days Payable is 58.08. Health Catalyst's value of 27.22 is 53.1% below this benchmark. Historically, Health Catalyst's own Days Payable has ranged from 6.97 to 23.80 over the past decade. While the company's 10-year median is 13.16 vs. the industry median of 58.08, Health Catalyst has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.08, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Health Catalyst's current Days Payable of 27.22 is 53.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Health Catalyst and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Catalyst's current Days Payable is 27.22, which is 107% above median its own 10-year median of 13.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Catalyst stock overvalued right now?
Based on GuruFocus' analysis, Health Catalyst (HCAT) is currently considered Possible Value Trap. The stock's GF Value™ is $5.06, compared to a current price of $1.72 — trading 66% below its estimated fair value. The current Days Payable is 27.22, which is 107% above median its 10-year median of 13.16 and 53.1% below the Healthcare Providers & Services industry median of 58.08. Health Catalyst's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Health Catalyst (HCAT), the current Days Payable is 27.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Health Catalyst (HCAT) Overvalued in 2026?
Based on GuruFocus' analysis, Health Catalyst stock appears to be undervalued.
The current stock price of $1.72 is trading 66% below its estimated GF Value™ of $5.06.
GuruFocus considers Health Catalyst to be Possible Value Trap.
Key valuation signals for HCAT:
Days Payable: 27.22 (107% above median its 10-year median of 13.16)
GF Value™: $5.06 vs. price of $1.72 (66% below fair value)
Industry Position: 53.1% below the Healthcare Providers & Services median (#506 of 608)
No single metric tells the full story. See the HCAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
49GF Score
Get the complete analysis for HCAT
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HCAT has been successfully added to your 
